Xiaojin Shi, MD
AstraZeneca
1
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
L Jin
Fudan University Affiliated Cancer Hospital
Shared therapeutic areas:
Z Y Ping
Zhejiang Provincal Cancer Hospital
Shared therapeutic areas:
Eric FRANCOIS, Dr
Centre Antoine Lacassagne, Nice
Shared therapeutic areas:
L Wei
HeBei Medical University Fouth Hospital
Shared therapeutic areas:
B Feng
Sichuan University Huaxi Hospital
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
L H Jie
The Third Military University Affiliated First Hospital
Shared therapeutic areas:
L Y Hong
Zhongshan University Affliated Cancer Hospital
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
X J Ming
Affiliated Hospital of Chinese PLA Military Academy of Medical Science
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
All 1 trials loaded